Pieris Pharmaceuticals GmbH   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2001)

Organization Overview

First Clinical Trial
2010
NCT01141257
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Pieris Australia Pty Ltd | Pieris Pharmaceuticals | Pieris Pharmaceuticals GmbH | Pieris Pharmaceuticals, Inc.